Copyright
©The Author(s) 2018.
World J Gastroenterol. Oct 21, 2018; 24(39): 4448-4461
Published online Oct 21, 2018. doi: 10.3748/wjg.v24.i39.4448
Published online Oct 21, 2018. doi: 10.3748/wjg.v24.i39.4448
Figure 3 Nuclear factor kappa-light-chain-enhancer of activated B cells and transforming growth factor beta expression in pancreatic tissues.
A: Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and transforming growth factor beta (TGF-β) expression in pancreatic acinar cells and inflammatory cells; B: Immunohistochemistry assay for NF-κB expression; C: Immunohistochemistry assay for TGF-β expression. Negative: Blue; Positive: Yellow-brown. The results are presented as the mean ± SD. aP < 0.05 vs NG; bP < 0.05 vs HLG. NF-κB: Nuclear factor kappa-light-chain-enhancer of activated B cells; TGF-β: Transforming growth factor beta; NG: Normal group; HLG: High-fat diet group; HSG: High-fat diet group treated with Sheng-jiang powder; N/P ratio: Nuclear/cytoplasmic ratio; AC: Acinar cells; IC: Inflammatory cells.
- Citation: Miao YF, Li J, Zhang YM, Zhu L, Chen H, Yuan L, Hu J, Yi XL, Wu QT, Wan MH, Tang WF. Sheng-jiang powder ameliorates obesity-induced pancreatic inflammatory injury via stimulating activation of the AMPK signalling pathway in rats. World J Gastroenterol 2018; 24(39): 4448-4461
- URL: https://www.wjgnet.com/1007-9327/full/v24/i39/4448.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i39.4448